Latest News On Drug Costs

Latest California Healthline Stories

Podcast: KHN’s ‘What The Health?’ Still More ‘Medicare-For-All’

Sarah Kliff of Vox.com, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss the latest version of a “Medicare-for-all” bill by Sen. Bernie Sanders (I-Vt.), a presidential hopeful, and Democratic and Republican reactions to it. They also discuss the latest on congressional efforts to rein in drug prices and another state effort to expand Medicaid — but not exactly in the way voters wanted. Also, Rovner interviews Ceci Connolly of the Alliance of Community Health Plans.

The Blame Game: Everyone And No One Is Raising Insulin Prices

During Wednesday’s House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade’s 300% price increase, frustrating congressional representatives.

Can Someone Tell Me What A PBM Does?

The Senate Finance Committee’s third drug-pricing hearing focused on pharmacy benefit managers, and was more of a fact-finding mission on how these companies operate than a debate about policy proposals.